Brickell Biotech to Participate at William Blair’s Biotech Focus Conference 2021
Brickell Biotech, a clinical-stage pharmaceutical company, has announced its participation in one-on-one investor meetings at the William Blair Biotech Focus Conference 2021, happening virtually from July 14-15. The company focuses on developing innovative therapeutics for debilitating skin diseases, particularly its lead asset, sofpironium bromide, aimed at treating hyperhidrosis. Brickell's management team boasts extensive experience in product development and commercialization from their roles in major pharmaceutical companies.
- None.
- None.
BOULDER, Colo., July 06, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that its management team will participate in one-on-one investor meetings at the upcoming William Blair Biotech Focus Conference 2021, taking place virtually July 14 - 15.
About Brickell
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell’s executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®. Brickell’s strategy is to leverage this experience to in-license, acquire, develop and commercialize innovative and differentiated pharmaceutical products that Brickell believes can be successful in the marketplace and transform lives by solving currently unmet patient needs. For more information, visit https://www.brickellbio.com.
Brickell Investor Contact:
Dan Ferry
LifeSci Advisors
(617) 430-7576
daniel@lifesciadvisors.com
FAQ
What is Brickell Biotech's focus?
When is the William Blair Biotech Focus Conference 2021?
What is the stock symbol for Brickell Biotech?
Who will represent Brickell Biotech at the conference?
